Tag | Content |
---|
EnhancerAtlas ID | HS098-32484 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr2:191845390-191847100 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EBF1 | MA0154.3 | chr2:191846852-191846866 | TTTCCCTTGGGAAT | + | 6.05 | EBF1 | MA0154.3 | chr2:191846852-191846866 | TTTCCCTTGGGAAT | - | 6.88 | POU4F2 | MA0683.1 | chr2:191846036-191846052 | GACATTATTTATGCAT | - | 6 | ZNF263 | MA0528.1 | chr2:191845740-191845761 | CCCCTTTTCCCTCCCTCCTCT | - | 7.14 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_17641 | chr2:191843666-191848102 | CD4p_CD25-_CD45RAp_Naive | SE_18370 | chr2:191844049-191848201 | CD4p_CD25-_Il17-_PMAstim_Th | SE_38535 | chr2:191841879-191847118 | HUVEC |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I190979 | chr2 | 191844227 | 191846774 |
|
Enhancer Sequence | AGGACCTAAA CAAATAAAAA CCAGATTTTT CAGCAAACAG AAACTGATTC TAAAGCTTTG 60 GTTGGACGGA TGGCTCTTGT ATTTGCTCTC AAGGAAAAGA GCCAAACACC CAACAAAGAT 120 TGTATGTACA CAGTTGACAT TTTCGGATAC CTTAATGCCA AATTAACTGA GCAATTATAA 180 TACGTGCTGT AAGAGGGCGG AATTTAAATG GTCTAAAATA TGTATATGTT GGTTTGAGTT 240 TAATGGCAGA AAGGAATGGA TGGCAGATTC CTGGGCACCA CGATATGAGA GTTTTTAGGG 300 AAAGCGGAAA CATCACAAAG CCTTACCATC TGCTCTCTCC CTCCCCAGCC CCCCTTTTCC 360 CTCCCTCCTC TAAAGAGAGG ACAGTCCTTT TAATGCCTCT TCATGTTACA CTTCCTTCCA 420 AGACCATCAG CTGACTTTGC CTTTTGCACT AAATCAAAGG TGTTCTGCTG GGCCTCCTAG 480 AGAAGCCTCC CTATCCAGTG CCTCTTCCCA CTGCCTTCCT CTGCTGCTCA GCAGAGCCCC 540 CTCTCCCAAG GATCCTACAG AATTTTTTTC AAAGTTCAAC CTAGGTGCCC AAGATCACCC 600 CTAGATCTTC AATGTAACTG ATACTTGACT TTACAAGTTT ATTTTAGACA TTATTTATGC 660 ATTTCCCTCA GCTTTCCTCC AAATAGGACA TGGGCTCAGG CAGTCTGATG CAAATCAAAA 720 ACCAAGTGAG AGAAACGAGA GGAAGAAGCC CGGGGTTATT AGCTACACAA ATTAAAGCAG 780 CCTGGGCGAG AAGAGGCGGT AAGCCCATTA TCGGTCTTCA AAGAGAACTA CAAATGAGCC 840 ATTACAGCTA GAAAAGATAT CCTTCTTAAC TCTCACCAAA TAAAGAAATG GAATAAGGGG 900 ATTTTGTACT TGTATTAAAC AGCACAAGAC CACCACTGTG ACAGCTGCAT ATCCAAGAGA 960 AGAAGGCACT GTTGAAAGTC ACTGAGTTAG GAAGAGCCTA CTGCTGTTTG GAGTAAATGC 1020 AGTGCTGCTC TACAGAAAGC AAATCTGGAT ACAAGTTGTC CACGGATTTT TAAAGAAATA 1080 GTTCAGATAG CCTCACTCAC TGAAAGATCT GACCTTGAGA CTAGTGGATC TTTGATTTGT 1140 TTAGTATGAA GGACTAATAA ATGCACTGAC ATTAACCACT GAAAGGGAAT TATCTACCAC 1200 TGTCTAGACT CTGTCCAATC AGGCAAAACT GCAGATCAAA AGAGGCATCC TCTTGTGGGG 1260 ACGGCATCCT CTGCTACCTG GGCCCCACCT GAGGCAAGGG CCCTGGGTTT ATGCTGCAGT 1320 GGGCAAGCCC CAGGACTTTA TTTCTCATCA TGTCAGGGAC TTCCTTTTTT CTCCCCAAGG 1380 TTAATGGTTA ATAGGCCTTC ATCTTTCTCA TCCAGGAACT TATTTCAGCC ACAAATAATA 1440 TATTTTACAT AATTCATAAA ACTTTCCCTT GGGAATTCAT CTCAGAAATC TTAATATGAG 1500 ACAATGAGGA ACGGATTCAT TTAAATGTTA TCAGGTCTAT ATTTCTTTCT AAGGTGACAT 1560 ATGATTCTCA CTTAGCTATA ATAAACTATA GCTTGAAAAG CTGACAGATT TTAGTACTTT 1620 TTTACCTTTA ACAAAATAGC AGAGGGGAAA AGAGCAATTA GAGAGATATT TTTATGAATT 1680 TCAATTTTTA TAAACATAAC AAGTTAATAT 1710
|